Discover
ALDX
Aldeyra Therapeutics, Inc.
2.43
2 x 1.78
2 x 2.72
bid
ask
+
0.30
14.08%
2 @ 05:36 AM
2.43 +0.00 (0.00%)
| Ytd | -53.09% | |
| 1y | -38.17% |
2.10
day range
2.53
1.07
52 week range
6.17
| Open | 2.13 | Prev Close | 2.13 | Low | 2.10 | High | 2.53 | Mkt Cap | 146.58M |
| Vol | 3.41M | Avg Vol | 1.40M | EPS | -0.45 | P/E | N/A | Forward P/E | -7.80 |
| Beta | 1.43 | Short Ratio | 6.19 | Inst. Own | 62.19% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 1.74 | 200-d Avg | 3.83 | 1yr Est | 10.00 |
| Income Statement | |||
| Operating Expenses | 3.55M | ||
| Research and Development Expense | 2.41M | ||
| Selling, General and Administrative Expense | 1.14M | ||
| Operating Income | -3.55M | ||
| Interest Expense | 468.68K | ||
| Net Income | -3.45M | ||
| Net Income Common Stock | -3.45M | ||
| Net Income Common Stock (USD) | -3.45M | ||
| Consolidated Income | -3.45M | ||
| Earnings per Basic Share | -0.06 | ||
| Earnings per Basic Share (USD) | -0.06 | ||
| Earnings per Diluted Share | -0.06 | ||
| Earning Before Interest & Taxes (EBIT) | -2.98M | ||
| Earning Before Interest & Taxes (USD) | -2.98M | ||
| Weighted Average Shares | 60.32M | ||
| Weighted Average Shares Diluted | 60.32M | ||
| Balance Sheet | |||
| Cash and Equivalents | 65.00M | ||
| Cash and Equivalents (USD) | 65.00M | ||
| Current Assets | 66.27M | ||
| Property, Plant & Equipment Net | 209.26K | ||
| Total Assets | 66.48M | ||
| Debt Current | 15.51M | ||
| Total Debt | 15.51M | ||
| Current Liabilities | 24.33M | ||
| Total Liabilities | 24.33M | ||
| Accumulated Retained Earnings (Deficit) | -487.41M | ||
| Shareholders Equity | 42.16M | ||
| Shareholders Equity (USD) | 42.16M | ||
| Assets Non-Current | 209.26K | ||
| Total Debt (USD) | 15.51M | ||
| Deferred Revenue | 6.00M | ||
| Trade and Non-Trade Payables | 141.36K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 66.60K | ||
| Net Cash Flow from Financing | 71.14K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.04M | ||
| Issuance (Purchase) of Equity Shares | 71.14K | ||
| Net Cash Flow from Operations | -5.11M | ||
| Share Based Compensation | -987.55K | ||